Michael G Overstreet

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Simon J Dovedi, Matthew J Elder, Chunning Yang, Suzanne I Sitnikova, Lorraine M Irving, Anna Hansen, James Hair, Des C Jones, Sumati Hasani, Bo Wang, Seock-Ah Im, Ben Tran, Deepa S Subramaniam, Shelby D Gainer, Kapil Vashisht, Arthur Lewis, Xiaofang Jin, Stacy Kentner, Kathy Mulgrew, Yaya Wang, Michael G Overstreet, James Dodgson, Yanli Wu, Asís Palazón, Michelle Morrow, Godfrey J Rainey, Gareth J Browne, Frances Neal, Thomas V Murray, Aleksandra D Toloczko, William Dall'Acqua, Ikbel Achour, Daniel J Freeman, Robert W Wilkinson, Yariv Mazor
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells. Cancer discovery 11 (5) (2021)
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, Elaine M Hurt, Suneetha B Thomas, Vanessa Muniz-Medina, Christopher Ward, Agnieszka Sadowska, Ryan Fleming, Subramanya Karanth, Shannon Breen, Bo Zheng, Yuling Wu, William O Iverson, Steven J Novick, Terrence O'Day, Dipesha P Shah, Nazzareno Dimasi, Arnaud C Tiberghien, Jane Osbourn, Jill Walker
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells. Molecular cancer therapeutics 19 (8) (2020)

Michael G Overstreet.css-eqlu8i{font-size:small;padding-left:4px;}